“C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells” (2013) Journal of Analytical Oncology, 2(4), pp. 195–208. doi:10.6000/1927-7229.2013.02.04.2.